Akamis Bio
UKWho owns Akamis Bio?
Akamis Bio is a British Biotech company, currently owned by IP Group since 2017 and Lundbeckfonden BioCapital.
Hand-verified · updated 2026-07-08
Open JSON · CC-BYKey facts
Ownership history
3 ownership periods · co-invest detected
Mercia Asset Management exited Akamis Bio in 2026 via Trade Sale after 11 years.
More from Lundbeckfonden BioCapital
Other portfolio companies in the same fund.
Denmark
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Akamis Bio?
Akamis Bio is currently owned by IP Group and Lundbeckfonden BioCapital, through Lundbeckfonden BioCapital, since 2017.
When did IP Group and 1 other acquire Akamis Bio?
IP Group and 1 other acquired Akamis Bio in 2017.
Who has owned Akamis Bio over time?
Akamis Bio has been through 3 private-equity ownership periods: Lundbeckfonden BioCapital · via Lundbeckfonden BioCapital · since 2012; Mercia Asset Management · via Mercia Direct Investments · 2015–2026 · (Trade Sale); IP Group · via IP Group (Evergreen) · since 2017.